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Abstract - Starting from the mucin nature of the CA125 antigen and conditions associated with high serum 
concentrations, this study is an attempt to gain insight into its activity profile towards human erythrocytes. Carcinoma-
associated and pregnancy-associated CA125 antigens were tested in agglutination/aggregation, adhesion and hemolysis 
assays. The results obtained indicated that CA125 antigens increased agglutination/aggregation and inhibited 
erythrocyte adhesion, but differed in their effective concentrations. Galectin-1 slightly modulated the effects observed. 
CA125 antigens had no effect on hemolysis. The activity profile of the CA125 antigen towards erythrocytes may have 
biomedical consequences in different microenvironments in relevant physiological and pathophysiological conditions. 
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INTRODUCTION 
CA125, a coelomic epithelium-related antigen, is a 
high molecular mass, structurally heterogeneous 
molecule
  (Yin et al., 2001; O’Brien et al., 2001). 
A l t h o u g h  i t  i s  a  w e l l - k n o w n  m a r k e r  o f  s e r o u s  
ovarian carcinoma, CA125 antigen is normally 
expressed during embryonic development and can 
also be present in some adult tissues (Jr. Zurawski 
et al., 1988). Besides the membrane form, high 
levels of soluble CA125 antigen are found in 
different body fluids, such as amniotic fluid, 
cervical mucus, maternal serum, umbilical cord and 
sera of cancer patients (Nustad et al., 2002).  
CA125 antigen has been recently categorized as a 
mucin, Muc16 (Yin et al., 2001; O’Brien et al., 2001). 
Mucins are extremely heterogeneous due to both 
genetic variations in the polypeptide chain and in the 
composition and type of carbohydrates (Carraway 
and Hull, 1991; Gum, 1992; Desseyn, 2008; Hattrup 
and Gendler, 2008; http://www.medkem.gu.se/ 
mucinbiology/databases/). Their expression was 
found to change characteristically during both normal 
physiological and pathophysiological conditions and 
some of them are relevant as diagnostic biomarkers. It 
is thought that their biological function is both 
protective, i.e anti-adhesive due to the negatively 
charged structure, and adhesive due to the ligand 
properties for specific receptors on particular cells 
(Van Klinken et al., 1995; Theodoropoulos and 
Carraway, 2007; Hattrup and Gendler, 2008; 
http://www.medkem.gu.se/mucinbiology/databases/).  
The biological function of the CA125 antigen is 
ill-defined. So far, galectin-1 and mesothelin have 
been reported as CA125-interacting molecules and 
the interaction with mesothelin was found to mediate 
heterotypic cell adhesion and may contribute to the 
metastasis of ovarian cancer to the peritoneum 
(Seelenmeyer et al., 2002; Rump et al., 2004). In 
addition, there are indications that the CA125 antigen 
has a complement-inhibiting effect which may also 
induce specific immunomodulation by suppressing 
NK cell-mediated cytotoxicity (McDonnel et al., 2003; 
Patankar et al., 2005). The most recent data suggest 
that Muc16 is a barrier to trophoblast adherence to 
the endometrium (Gipson et al., 2008). 
Homotypic and heterotypic cellular interactions 
important for metabolic, transport and immune 
functions  are  greatly  influenced by the (anti)- adhe- 272 N.  MITIĆ  AND MIROSLAVA JANKOVIĆ 
 
 
Figs. 1 A-C. Assessment of erythrocyte agglutination/aggregation in the presence of CA125 antigens. 
Erythrocyte suspensions were placed as droplets on to glass slides and then CA125 from human placenta – pCA125 (Fig. 1-A),
CA125 from human pleural fluids – pfCA125 (Fig. 1-B) or CA125 from ovarian carcinoma cell line – clCA125 (Fig. 1-C) were 
added. After 30 min incubation at room temperature the cells were observed under a light microscope (x20 and x40 magnification) 
and representative fields were photographed. 
Fig. 1-A.  500 IU/mL pCA125 (a, b); 500 IU/mL pCA125 preincubated with 2.5 μg/mL human gal-1 (c, d); Erythrocyte suspension 
without added CA125 antigen, used as the reference (e, f). 
Fig. 1-B.  20000 IU/mL pfCA125 (a, b); 4000 IU/mL pfCA125 (c, d); 20000 IU/mL pfCA125 preincubated with 2.5 μg/ml human gal-
1 (e,f); 4000 IU/mL pfCA125 preincubated with 2.5 μg/ml human gal-1 (g, h). 
Fig. 1-C.  20000 IU/mL clCA125 (a);  20000 IU/mL clCA125 preincubated with 2.5 μg/ml human gal-1 (b); 4000 IU/mL clCA125 (c);
4000 IU/mL clCA125 preincubated with 2.5 μg/ml human gal-1 (d).   ACTIVITY PROFILE OF THE CA 125 ANTIGEN  273 
sive/aggregative and/or template properties of mucins. 
It is reported that various mucins existing as 
membrane-bound or soluble forms can significantly 
affect the recognitive and functional properties of 
different cells, including blood cell types. Thus, there 
are data that mucins generally have a procoagulation 
role in the circulation and increase the aggregability 
and adhesiveness of blood cells. As for malignant 
transformation, several phenomena related to blood 
cell agglutination/aggregation and mucins production 
have been described. The Trousseau's syndrome, 
disseminated intravascular coagulopathy, with mig-
ratory thrombosis was found to be associated with 
occult malignancy and abnormally glycosylated mu-
cins secreted, while adenocarcinomas were most 
frequently associated with non-bacterial thrombotic 
endocarditis (Wahrenbrock et al., 2003; Varki, 2007). 
In cancer patients, cerebrovascular accidents are the 
most common complication occurring in the central 
nervous system after metastasis, and gynecological 
malignancies are reported to have the closest relation 
with ischemic stroke (Higes-Pascual et al., 2005; Bo-
rowski et al., 2005). Specifically, a high titer of CA125 
is suggested to be associated with recurrent ischemic 
strokes in patients with cancer (Jovin et al., 2005). 
In this context, this study was aimed at providing 
complementary data on the CA125 antigen (Muc16), 
i.e. to examine its effects on human red blood cells, 
which have not been studied so far. Cancer-derived and 
pregnancy-associated CA125 antigens previously re-
ported to have distinct structural differences in both 
protein and glycan composition were used in assays of 
adhesiveness, agglutination/aggregation and hemolysis 
of erythrocytes from normal human subjects. The 
results obtained indicate that, depending on the source, 
the CA 125 antigen can act differently as an elicitor of 
these specific red blood cell responses in a concen-
tration-dependent mode. 
MATERIALS AND METHODS 
Material 
Human CA125 antigens: CA125 from human pleural 
fluids from subjects with ovarian carcinoma (code 
A32303H) and CA125 antigen from ovarian 
carcinoma cell line (code A97180H) were from 
M e r i d i a n  L i f e  S c i e n c e ,  Inc. (Saco, ME, USA). 
Pregnancy-associated CA125 antigen was isolated 
from first trimester human placenta as previously 
described (Janković and Tapusković, 2005). Bovine 
serum albumin (BSA) and poly-L-lysine were from 
Sigma-Aldrich (St. Louis, USA). Recombinant human 
galectin-1 (gal-1) was from R and D systems, 
Minneapolis, USA. The concentration of CA125 was 
estimated immunoradiometrically using an ELSA 
CA125 II kit (Cis-bio international – Schering, 
Germany). All other chemicals were reagent grade.  
Erythrocytes 
Blood samples were drawn from apparently healthy 
consenting volunteers with different blood types, 
according to local ethical standards. Blood was collec-
ted in EDTA-containing tubes, the erythrocytes were 
subsequently separated by centrifugation (500 x g for 
10 minutes), and washed three times with physio-
logical saline. The cell count was recorded using a 
Mythic 18 blood analyzer (CZ diagnostic, France). 
Cell agglutination/aggregation assay 
The erythrocyte agglutination/aggregation assay was 
performed with slight modifications as previously 
described (Ueda and Takeichi, 1976; Takeichi, 1977). 
A 0.1% erythrocyte suspension (1x10
5 cells/25 μL) was 
placed as a droplet onto a glass slide and then the 
corresponding CA125 antigens (25μL) in the 
concentration range, 500 – 20000 IU/mL, alone or 
preincubated with gal-1 (2.5 μg/mL) were added. A 
cell suspension without added CA125 antigen was 
used as the reference for comparison. Cells were 
examined under a light microscope (Reichert-Jung 
with Leica DC150 Digital Camera System, Wetzlar, 
Germany) for 30 minutes at room temperature by two 
independent observers. Representative fields were 
photographed using Canon s50. 
Erythrocyte adhesion 
The erythrocyte adhesion assay was performed with 
slight modifications as previously described (Tas et al., 274 N.  MITIĆ  AND MIROSLAVA JANKOVIĆ 
1999). A 10% erythrocyte suspension in 8 mM TRIS-
HCl, pH 7.4 containing 0.1 M NaCl, 0.14 M glucose, 
0.45 mM CaCl2 and 0.17 mM MgCl2 (adhesion buffer) 
was used. The cells were placed on glass slides 
(1x10
7cells/25 μL/drop) or added (1x10
7cells/25 
μL/well) to 96 well microtiter plates (Corning Incor-
porated, Corning, NY, USA) both previously coated 
with 0.1 % poly-L-lysine (Sigma Aldrich, USA) and 
b l o c k e d  w i t h  1 %  B S A .  T h e y  w e r e  i n c u b a t e d  f o r  6 0  
minutes at room temperature in the presence of the 
corresponding CA125 antigens alone (50-20000 
IU/mL; 12.5 μL) or preincubated with gal-1 (2.5 
μg/mL; 12.5 μL). A cell suspension without added 
CA125 antigen was used as the reference. Non-
adherent cells were removed by gentle washing with 
adhesion buffer (four times, 200 μL each). Cells 
adhered to the glass slides were then observed at x 20 
and x 40 magnification and representative fields were 
photographed. Cells adhered to the microtiter plates 
were subsequently lysed by the addition of distilled 
water (50 μL/well) and the absorbance at 405 nm, as a 
measure for total cell count, was recorded using a 
5060-006 microplate reader (LKB, Austria). Adhesion 
assays in microtiter plates were performed in dupli-
cate and the absorbance mean ± SD calculated. The 
results were expressed as a percentage of the control 
reference sample. 
Hemolysis 
The hemolysis assay was performed as previously 
described (Timoshenko et al., 2003). A 1 % suspen-
sion of human erythrocytes in physiological saline 
(5x10
6cells/50μL/well) was incubated with 125 μM 
SDS (225 μL/well) in the presence or absence of the 
corresponding CA125 antigens (concentration range 
500-2000 IU/mL; 25μL) at 25
0C for 3 hours. Cell 
suspensions were constantly stirred and the absor-
bance at 670 nm was recorded at 15 minute intervals. 
Statistics 
The results of the adhesion assay are presented 
as the mean ± SD for three experiments which 
were independently performed with different 
batches of isolated red blood cells. Group results 
were compared using the t–test and the p value 
calculated (Primer of Biostatistics Version 5.0 
statistics software). 
RESULTS 
Agglutination/aggregation response of human 
erythrocytes to CA125 antigen 
Representative results of slide test analysis of the 
state of erythrocyte agglutination/aggregation in the 
presence of CA125 antigen are shown in Fig. 1, A-C. 
In contrast to the control sample where cells were 
spread individually (Fig. 1-A e, f), formation of 
grape-like miniclusters was marked in the presence 
of pregnancy-associated CA125 antigen, pCA125 
(Fig. 1-A a, b) and at higher concentrations in the 
presence of CA125 from human pleural fluids, 
pfCA125 (Fig. 1-B a-d). Individual cells within ag-
gregates remained round and the aggregate morpho-
logy formed in the presence of both antigens was 
similar. Thus, the ability of pCA125 to potentiate 
agglutination/aggregation was moderately higher 
than that of pfCA125. Comparable results were 
obtained when these CA125 antigens preincubated 
with human gal-1 were tested, indicating 
maintenance of dendrite aggregate outlines (Fig. 1-A 
c, d; Fig. 1-B e-h) compared to the control samples 
(Fig. 1-A e, f). In contrast CA125 from the ovarian 
carcinoma cell line, clCA125, alone (Fig. 1-C a, c) or 
preincubated with gal-1 (Fig. 1-C b, d), had a much 
weaker effect on erythrocyte agglutina-
tion/aggregation than pCA125 and pfCA125. 
Influence of CA125 antigen 
on erythrocyte adhesion 
The effect of CA125 antigens on erythrocyte adhe-
sion to poly-L-lysine-coated surfaces is shown in 
Fig. 2 and Fig. 3. The pCA125 antigen exhibited 
concentration-dependent inhibition (up to 23% of 
the control value) of adhesion (Fig. 2-A), whereas 
the pfCA125 antigen (Fig. 2-B) and clCA125 
antigen (Fig. 2-C) were less effective at the same 
concentration tested (up to 83 % and 85 % of the 
control value, respectively). At 20-40 times higher 
concentration, pfCA125 exhibited a similar effect as   ACTIVITY PROFILE OF THE CA 125 ANTIGEN  275 
 
 
Fig. 2. Influence of CA125 antigen on the adhesion of human erythrocytes to poly-L-lysine.  
96 well microtiter plates were coated with poly-L-lysine, blocked with BSA, and then corresponding CA125 antigens and human 
erythrocytes were added and incubated for 1 hour at room temperature. The non-adherent cells were removed by gentle washing 
with adhesion buffer, and cells adhered to the microtiter plate were subsequently lysed by addition of distilled water. The absorbance 
at 405 nm was recorded as a measure of the total count of adherent cells. The adhesion assay was done in duplicate and the 
absorbance mean ± SD was calculated and expressed as a percentage of the control reference sample without added CA125 antigen. 
The results are presented as the mean ± SD for three experiments performed independently with different batches of isolated red 
blood cells. 
Panel A: pCA125 antigen alone (dark grey; concentration range 10 - 500 IU/mL) or preincubated with gal-1 (light grey) 
Panel B: pfCA125 antigen alone (dark grey; concentration range 200-20000 IU/mL) or preincubated with gal-1 (light grey) 
Panel C: clCA125 antigen alone (dark grey; concentration range 200-20000 IU/mL) or preincubated with gal-1 (light grey) 276 N.  MITIĆ  AND MIROSLAVA JANKOVIĆ 
pCA125 (up to 19% of the control value), whereas 
the clCA125 antigen was less potent (65% of the con-
trol value).  
The presence of gal-1 (Fig. 2-A, B, C) did not 
change the CA125-induced inhibition of adhesion 
significantly (up to 31 % for pCA125, 84 % for 
pfCA125, and 95 % for clCA125).  
The adhesion assay was performed in parallel 
on poly-L-lysine-coated glass slides. The findings 
for pCA125 (Fig. 3-b,c), pfCA125 (Fig. 3-a1,b1,c1) 
and clCA125 (Fig. 3-a2,b2,c2) confirmed the results 
obtained in the assays on microtiter plates.  
Erythrocyte hemolysis in the presence of CA125 
antigens 
The results for detergent-mediated hemolysis of 
human red blood cells in the presence of CA125 
antigens from different sources are presented in Fig. 
4. They indicate no differences in the half-time of 
hemolysis in the presence of any of the three 
examined CA125 antigens (concentration range 
500-20000 IU/mL) compared to the control without 
added antigen, i.e. that the antigens tested did not 
affect SDS-induced hemolysis. 
DISCUSSION 
Starting from the mucin nature of the CA125 
antigen and conditions associated with high serum 
concentrations, we have attempted to gain initial 
insight into the activity profile of CA125 antigen 
against human red blood cells. Agglutination/ag-
gregation, adhesion and hemolysis were tested 
experimentally  in vitro, and the results obtained 
indicated that the CA125 antigen can modulate 
these erythrocyte properties differently, depending 
on the source of antigen tested. We examined 
CA125 antigen isolated from first trimester human 
placenta and two carcinoma-associated CA125 
antigens, one from the pleural fluids of patients 
with ovarian carcinoma and the second from an 
ovarian carcinoma cell line. Previous studies on 
pregnancy-associated CA125 antigens and CA125 
antigen from an ovarian carcinoma cell line 
indicated distinct structural differences in both 
protein and glycan moieties (Janković and 
Tapusković, 2005; Janković and Milutinović, 2007, 
2008). In this investigation pregnancy-associated 
CA125 antigen and CA125 from human pleural 
fluids had similar effects on the agglutination/ag-
gregation and adhesion of human erythrocytes but 
differed in their effective concentration ranges. 
Thus, both antigens moderately increased agglu-
tination/aggregation and efficiently inhibited eryth-
rocyte adhesion to poly-L-lysine. In contrast to this, 
the CA125 antigen from the ovarian carcinoma cell 
line showed considerably less potency to modulate 
these erythrocyte characteristics.  
Red cell aggregation/adhesiveness is one of the 
most important determinants of rheological pro-
perties and the prediction of the risk of agglu-
tination/aggregation is of special medical impor-
tance due to its effect on blood flow (Chien and Jan, 
1973; Shiga et al., 1983). It was shown that during 
pregnancy, the agglutination/aggregation of eryt-
hrocytes is increased in both normal and patho-
logical conditions, such as hypertension and pre-
eclampsia (El Bouhmadi et al., 2000; Gamzu et al., 
2001). In addition, alteration in mucin production 
and structure during malignant transformation, 
including gynecological malignancies, is suggested 
to be associated with vascular/circulatory obstruc-
tions and ischemic stroke (Higes-Pascual et al., 
2005; Borowski et al., 2005; Jovin et al., 2005).  
The activity profiles of CA125 antigens towards 
human red blood cells were also tested in the 
presence of gal-1. Gal-1 belongs to the galectin 
family whose members share specificity for beta-
galactoside and aminoacid sequence homology in 
the carbohydrate-recognition domain (Leffler, 
1997, 2001). The concentration of gal-1 is known to 
be developmentally regulated and changes charac-
teristically during embryonic development and 
malignant transformation (Leffler, 1997, 2001). 
Specifically, gal-1 is upregulated in ovarian carcino-
ma and may have various roles in cell-cell and cell-
matrix interactions (Leffler, 1997, 2001; Camby et 
al., 2006). It was also identified as a counter receptor 
for CA125 (Seelenmeyer et al., 2002). The data    ACTIVITY PROFILE OF THE CA 125 ANTIGEN  277 
 
 
Fig. 3. Microscopic examination of the adhesion of human erythrocytes in the presence of CA125 antigens. 
Microscopic slides were coated with poly-L-lysine, blocked with BSA and then the corresponding CA125 antigens and human 
erythrocytes were added and incubated for 1 h at room temperature. After gentle washing, adherent erythrocytes were observed 
under a light microscope. Magnification x20 (x40 for inserts). 
Control: erythrocyte adhesion to poly-L-lysine coated glass in the absence of CA125 antigen.  
CA125 antigen from human placenta, pCA125: b) 500 IU/mL and c) 50 IU/mL; CA125 antigen from human pleural fluids, pfCA125: 
a1) 20000 IU/mL, b1) 5000 IU/mL and c1) 500 IU/mL; CA125 antigen from ovarian carcinoma cell line, clCA125: a2) 20000 IU/mL, b2) 
5000 IU/mL and c2) 500 IU/mL. 278 N.  MITIĆ  AND MIROSLAVA JANKOVIĆ 
 
provided indicated that the O-linked beta-galactose 
of the CA125 antigen has a high impact on the 
interaction with gal-1 and that it is regulated 
differently in different cellular backgrounds in 
which they are expressed
 (Seelenmeyer et al., 2002). 
Under our experimental conditions, gal-1 slightly 
modulated the effects on human erythrocytes of 
CA125 from all three sources. However, agglutina-
tion/aggregation and adhesion were not significan-
tly changed compared to control binding without 
added gal-1. In contrast to other galectins, gal-1 did 
not influence the osmofragility of human erythro-
cytes (Timoshenko et al., 2003), which was confir-
med here, as CA125 antigens were found to have no 
effect on detergent-induced hemolysis of human 
erythrocytes. Taken together, these data suggest 
that the effects observed might be due predominan-
tly to protein-protein interactions rather than car-
bohydrate-binding interactions.  
CA125 contains 14 LRR (leucine-rich repeats), 56 
SEA (sperm protein, enterokinase and agrin) domains 
and 2 ANK (ankyrin) repeats. The SEA domains in 
different adhesive proteins are associated with O-
glycosylation and are thought to regulate or assist 
binding to neighboring carbohydrate moieties 
(http://www.expasy.org/cgi-bin/nicedoc.pl?PS50024; 
Maeda et al., 2004). Ankyrin repeats represent an 
ancient motif occurring in a large number of 
functionally diverse proteins and they function as 
protein-protein interaction domains (Sedgwick and 
Smerdon, 1999; Bennett and Baines, 2001). Thus, the 
complexity of CA125 structure suggests that it can act 
as a multifunctional molecule, i.e.  both the protein 
and carbohydrate parts may be involved in different 
 
Fig. 4 . Time course of SDS-induced hemolysis of human erythrocytes. 
Erythrocyte suspensions were incubated with 125 μM SDS in the presence of the corresponding CA125 antigens (500 IU/mL is 
shown) at 250C. Cell suspensions were constantly stirred for 3 h and the absorbance at 670 nm was recorded at 15 min intervals. 
Control: erythrocyte suspension incubated with 125 μM SDS in the absence of CA125 antigen. CA125 antigen from human placenta, 
pCA125: CA125 antigen from human pleural fluids, pfCA125: CA125 antigen from ovarian carcinoma cell line, clCA125.   ACTIVITY PROFILE OF THE CA 125 ANTIGEN  279 
kinds of interactions at different levels of cell and 
tissue organization.  
Accordingly, the activity profile of the CA125 
antigen towards human red blood cells may have 
biomedical consequences in different microenvi-
ronments in relevant physiological and patho-
physiological conditions and this indicates the need 
for interdisciplinary investigation of its multi-func-
tionality based on the complexity of various 
domain-dependent interactions. 
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